Texas Attorney General Sues Dallas Doctor for Allegedly Prescribing Illegal Gender Transition Drugs to Minors

Texas Attorney General Ken Paxton has filed a lawsuit against a second Dallas-area physician accused of illegally dispensing “gender transition” drugs to minors. This lawsuit is the third of its kind as Paxton enforces Senate Bill 14, a Texas law that bans the provision of such medical interventions to individuals under 18. The law took effect in September 2023 and was upheld by the Supreme Court of Texas in June 2024, as reported by the

Texas Attorney General

.

According to the

Texas Attorney General

, there is substantial scientific evidence showing long-term negative effects of “gender transition” drugs when given to children. The release details a recent case against a doctor who continued providing these treatments on September 25, despite legal restrictions under SB 14. Paxton’s office also claims that the doctor used deceptive record-keeping practices to conceal their illegal actions.

SB 14 makes it illegal for doctors in Texas to prescribe puberty blockers, hormones, or perform surgeries to alter a minor’s sex characteristics. Medical professionals who violate the law may face penalties, including losing their medical license. Attorney General Paxton stated, “These medical professionals cannot willfully ignore the law and endanger the health of young people.” The law is part of a broader debate about healthcare for transgender minors, with supporters saying it protects children from irreversible treatments, while opponents argue it goes against recommended medical practices for transgender youth, as stated by the

Texas Attorney General

.

Note: Thank you for visiting our website! We strive to keep you informed with the latest updates based on expected timelines, although please note that we are not affiliated with any official bodies. Our team is committed to ensuring accuracy and transparency in our reporting, verifying all information before publication. We aim to bring you reliable news, and if you have any questions or concerns about our content, feel free to reach out to us via email. We appreciate your trust and support!